I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Jaktinib Hydrochloride for the Treatment of Ruxolitinib Intolerance of Myelofibrosis
This phase IIB, open-label, multicenter study evaluated the efficacy and safety of oral Jaktinib Dihydrochloride in Intermediate-risk and High-risk Myelofibrosis and Previously Treated With Ruxolitinib
thrombocytosis
direct bilirubin
ruxolitinib
essential thrombocythemia
iron
- 0 views
- 19 Feb, 2024
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
This phase II trial studies how well decitabine with ruxolitinib or fedratinib works before hematopoietic stem cell transplant in treating patients with accelerated/blast phase myeloproliferative neoplasms (tumors). Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, …
thrombocytosis
polycythemia vera
myeloid leukemia
myelodysplastic/myeloproliferative neoplasm
wbc count
- 0 views
- 19 Feb, 2024